PRAXIS.NSPRAXIS.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -46.97% | -41.10% | -25.30% | -19.47% | -22.85% |
| Gross Profit Growth | +69.42% | +144.23% | -45.51% | -100.11% | -91.25% |
| EBITDA Growth | +0.00% | +0.00% | -257.77% | +906.69% | -991.79% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.23% | +3.40% | +3.00% | +18.01% | +32.12% |
| Weighted Average Shares Diluted Growth | +12.23% | +3.40% | +3.00% | +15.25% | +32.12% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -57.83% | +0.00% | +222.58% | +0.00% |
| Inventory Growth | +0.00% | -34.67% | +0.00% | -42.28% | +0.00% |
| Asset Growth | +0.00% | -1.83% | +0.00% | +4.63% | +0.00% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +0.00% | +36.27% | +0.00% | -26.86% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -73.05% | -86.75% | -100.00% | -100.00% | +54.90% |